Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
22-Feb-2021
Appendix 4D and Half Year Accounts
16-Feb-2021
Lapsing of balance of Unlisted SAB Options
16-Feb-2021
Cleansing Statement
16-Feb-2021
Appendix 2A
1-Feb-2021
NYR Secures Collaboration with Walter Reed and UNSW
29-Jan-2021
Trading Halt
28-Jan-2021
Nyrada Quarterly Activities Report & Appendix 4C
25-Jan-2021
Nyrada Reports Further Results from Cholesterol Study
22-Jan-2021
Unlisted Scientific Advisory Board Options Expiry 15 Feb 21
18-Jan-2021
Change of Director's Interest Notice - ID
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
